mIRT

mIRT is an RTSM (Randomization and Trial Supply Management) / IRT (Interactive Response Technology) software platform developed by DDi, designed for sponsors, sites, and patients involved in global clinical trials. It addresses the full lifecycle of clinical supply management, from planning and forecasting through to inventory management, drug accountability, and regulatory compliance. mIRT is intended to reduce the risks, complexities, workload, time, and costs associated with running clinical studies at scale.

The platform is structured around a modular, end-to-end approach, offering both a no-build configuration option for rapid deployment and a tailored option for complex, protocol-specific requirements. It supports advanced randomization methods, master protocols, basket trials, and multi-study bundling.

Core Modules and Capabilities

• mIRT Xpress is a ready-to-use, no-build platform that eliminates dependency on developers or vendors. Users configure it through an intuitive UI, reducing setup time and increasing study flexibility.
• mIRT (full platform) supports protocol-specific requirements including advanced randomization methods, master protocols, and basket trials, with real-time tracking for site, study, and subject management.
• mIRT Supplies is a dedicated clinical supplies forecasting and management module. It integrates with other tools and allows users to create and compare supply scenarios against trial objectives. It supports multiple forecasting models including Modified Holt, Moving Average, and Croston, providing a visual, interactive approach to supply chain optimization.

Reported Performance Metrics

• Reduces drug supply overages and outages by up to 30%
• Lowers cost of ownership by up to 40%
• Enables savings of up to 50% when bundling multiple studies on the platform

Key Platform Features

• End-to-end clinical supplies management covering planning, forecasting, inventory, and drug accountability
• Real-time tracking of sites, studies, and subjects
• Integration with external tools and systems
• Rapid study start-up capabilities
• Support for complex and adaptive trial designs including master protocols and basket trials
• Multiple forecasting models for supply scenario comparison and waste reduction
• Regulatory compliance support throughout the trial lifecycle

mIRT is part of DDi's broader clinical and regulatory software portfolio, which also includes TULA and other enterprise solutions. The platform is positioned for organizations seeking to reduce operational burden and cost in global clinical trial supply management, with integration and reporting capabilities designed to support both site-level and sponsor-level workflows.